Global CRISPR and CRISPR-Associated (Cas) Genes Market Insights and Forecast to 2028

Global CRISPR and CRISPR-Associated (Cas) Genes Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Genome Editing
1.2.3 Genetic engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Perspective (2017-2028)
2.2 CRISPR and CRISPR-Associated (Cas) Genes Growth Trends by Region
2.2.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Region (2017-2022)
2.2.3 CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (2023-2028)
2.3 CRISPR and CRISPR-Associated (Cas) Genes Market Dynamics
2.3.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
2.3.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
2.3.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
2.3.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue
3.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2017-2022)
3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Players (2017-2022)
3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR and CRISPR-Associated (Cas) Genes Revenue
3.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio
3.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2021
3.5 CRISPR and CRISPR-Associated (Cas) Genes Key Players Head office and Area Served
3.6 Key Players CRISPR and CRISPR-Associated (Cas) Genes Product Solution and Service
3.7 Date of Enter into CRISPR and CRISPR-Associated (Cas) Genes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Type
4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Type (2017-2022)
4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2023-2028)
5 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Application
5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Application (2017-2022)
5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
6.2.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
6.2.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
6.2.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
6.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
6.3.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
6.3.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
6.4 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
6.4.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
6.4.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
7.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
7.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
7.2.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
7.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
7.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
7.3.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
7.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
7.4.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
7.4.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
8.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
8.2.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
8.2.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
8.2.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
8.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
8.3.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
8.3.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
8.3.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
8.4 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region
8.4.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2017-2022)
8.4.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
9.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
9.2.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
9.2.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
9.2.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
9.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
9.3.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
9.3.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
9.3.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
9.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
9.4.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
9.4.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size (2017-2028)
10.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
10.2.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
10.2.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028)
10.2.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2017-2028)
10.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
10.3.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
10.3.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028)
10.3.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2017-2028)
10.4 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
10.4.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
10.4.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.1.4 Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Editas Medicine
11.2.1 Editas Medicine Company Details
11.2.2 Editas Medicine Business Overview
11.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.2.4 Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
11.2.5 Editas Medicine Recent Developments
11.3 Caribou Biosciences
11.3.1 Caribou Biosciences Company Details
11.3.2 Caribou Biosciences Business Overview
11.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.3.4 Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
11.3.5 Caribou Biosciences Recent Developments
11.4 CRISPR therapeutics
11.4.1 CRISPR therapeutics Company Details
11.4.2 CRISPR therapeutics Business Overview
11.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.4.4 CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
11.4.5 CRISPR therapeutics Recent Developments
11.5 Intellia therapeutics, Inc.
11.5.1 Intellia therapeutics, Inc. Company Details
11.5.2 Intellia therapeutics, Inc. Business Overview
11.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.5.4 Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
11.5.5 Intellia therapeutics, Inc. Recent Developments
11.6 Cellectis
11.6.1 Cellectis Company Details
11.6.2 Cellectis Business Overview
11.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.6.4 Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
11.6.5 Cellectis Recent Developments
11.7 Horizon Discovery Plc
11.7.1 Horizon Discovery Plc Company Details
11.7.2 Horizon Discovery Plc Business Overview
11.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.7.4 Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
11.7.5 Horizon Discovery Plc Recent Developments
11.8 Sigma Aldrich
11.8.1 Sigma Aldrich Company Details
11.8.2 Sigma Aldrich Business Overview
11.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.8.4 Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
11.8.5 Sigma Aldrich Recent Developments
11.9 Precision Biosciences
11.9.1 Precision Biosciences Company Details
11.9.2 Precision Biosciences Business Overview
11.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.9.4 Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
11.9.5 Precision Biosciences Recent Developments
11.10 Genscript
11.10.1 Genscript Company Details
11.10.2 Genscript Business Overview
11.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.10.4 Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
11.10.5 Genscript Recent Developments
11.11 Sangamo Biosciences Inc.
11.11.1 Sangamo Biosciences Inc. Company Details
11.11.2 Sangamo Biosciences Inc. Business Overview
11.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.11.4 Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
11.11.5 Sangamo Biosciences Inc. Recent Developments
11.12 Lonza Group Limited
11.12.1 Lonza Group Limited Company Details
11.12.2 Lonza Group Limited Business Overview
11.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.12.4 Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
11.12.5 Lonza Group Limited Recent Developments
11.13 Integrated DNA Technologies
11.13.1 Integrated DNA Technologies Company Details
11.13.2 Integrated DNA Technologies Business Overview
11.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.13.4 Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
11.13.5 Integrated DNA Technologies Recent Developments
11.14 New England Biolabs
11.14.1 New England Biolabs Company Details
11.14.2 New England Biolabs Business Overview
11.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.14.4 New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
11.14.5 New England Biolabs Recent Developments
11.15 Origene Technologies
11.15.1 Origene Technologies Company Details
11.15.2 Origene Technologies Business Overview
11.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.15.4 Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022)
11.15.5 Origene Technologies Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Genome Editing
Table 3. Key Players of Genetic engineering
Table 4. Key Players of gRNA Database/Gene Librar
Table 5. Key Players of CRISPR Plasmid
Table 6. Key Players of Human Stem Cells
Table 7. Key Players of Genetically Modified Organisms/Crops
Table 8. Key Players of Cell Line Engineering
Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2017-2022)
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2023-2028)
Table 15. CRISPR and CRISPR-Associated (Cas) Genes Market Trends
Table 16. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
Table 17. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
Table 18. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
Table 19. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Players (2017-2022)
Table 21. Global Top CRISPR and CRISPR-Associated (Cas) Genes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2021)
Table 22. Ranking of Global Top CRISPR and CRISPR-Associated (Cas) Genes Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players CRISPR and CRISPR-Associated (Cas) Genes Product Solution and Service
Table 26. Date of Enter into CRISPR and CRISPR-Associated (Cas) Genes Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2017-2022)
Table 30. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2023-2028)
Table 32. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Application (2017-2022)
Table 34. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Application (2023-2028)
Table 36. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2023-2028) & (US$ Million)
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product
Table 69. Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Developments
Table 71. Editas Medicine Company Details
Table 72. Editas Medicine Business Overview
Table 73. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product
Table 74. Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
Table 75. Editas Medicine Recent Developments
Table 76. Caribou Biosciences Company Details
Table 77. Caribou Biosciences Business Overview
Table 78. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 79. Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
Table 80. Caribou Biosciences Recent Developments
Table 81. CRISPR therapeutics Company Details
Table 82. CRISPR therapeutics Business Overview
Table 83. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product
Table 84. CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
Table 85. CRISPR therapeutics Recent Developments
Table 86. Intellia therapeutics, Inc. Company Details
Table 87. Intellia therapeutics, Inc. Business Overview
Table 88. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 89. Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
Table 90. Intellia therapeutics, Inc. Recent Developments
Table 91. Cellectis Company Details
Table 92. Cellectis Business Overview
Table 93. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product
Table 94. Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
Table 95. Cellectis Recent Developments
Table 96. Horizon Discovery Plc Company Details
Table 97. Horizon Discovery Plc Business Overview
Table 98. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product
Table 99. Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
Table 100. Horizon Discovery Plc Recent Developments
Table 101. Sigma Aldrich Company Details
Table 102. Sigma Aldrich Business Overview
Table 103. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product
Table 104. Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
Table 105. Sigma Aldrich Recent Developments
Table 106. Precision Biosciences Company Details
Table 107. Precision Biosciences Business Overview
Table 108. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 109. Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
Table 110. Precision Biosciences Recent Developments
Table 111. Genscript Company Details
Table 112. Genscript Business Overview
Table 113. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product
Table 114. Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
Table 115. Genscript Recent Developments
Table 116. Sangamo Biosciences Inc. Company Details
Table 117. Sangamo Biosciences Inc. Business Overview
Table 118. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 119. Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
Table 120. Sangamo Biosciences Inc. Recent Developments
Table 121. Lonza Group Limited Company Details
Table 122. Lonza Group Limited Business Overview
Table 123. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product
Table 124. Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
Table 125. Lonza Group Limited Recent Developments
Table 126. Integrated DNA Technologies Company Details
Table 127. Integrated DNA Technologies Business Overview
Table 128. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 129. Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
Table 130. Integrated DNA Technologies Recent Developments
Table 131. New England Biolabs Company Details
Table 132. New England Biolabs Business Overview
Table 133. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product
Table 134. New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
Table 135. New England Biolabs Recent Developments
Table 136. Origene Technologies Company Details
Table 137. Origene Technologies Business Overview
Table 138. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 139. Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2017-2022) & (US$ Million)
Table 140. Origene Technologies Recent Developments
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type: 2021 VS 2028
Figure 2. Genome Editing Features
Figure 3. Genetic engineering Features
Figure 4. gRNA Database/Gene Librar Features
Figure 5. CRISPR Plasmid Features
Figure 6. Human Stem Cells Features
Figure 7. Genetically Modified Organisms/Crops Features
Figure 8. Cell Line Engineering Features
Figure 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application: 2021 VS 2028
Figure 10. Biotechnology Companies Case Studies
Figure 11. Pharmaceutical Companies Case Studies
Figure 12. Academic Institutes Case Studies
Figure 13. Research and Development Institutes Case Studies
Figure 14. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered
Figure 15. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region: 2021 VS 2028
Figure 18. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players in 2021
Figure 19. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2021
Figure 21. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY (2017-2028) & (US$ Million)
Figure 22. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2028)
Figure 23. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2028)
Figure 24. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Country (2017-2028)
Figure 25. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY (2017-2028) & (US$ Million)
Figure 28. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2028)
Figure 29. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2028)
Figure 30. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Country (2017-2028)
Figure 31. Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. France CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. U.K. CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Nordic Countries CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY (2017-2028) & (US$ Million)
Figure 38. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2028)
Figure 39. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2028)
Figure 40. Asia Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Share by Region (2017-2028)
Figure 41. China CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Si

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Sanger Sequencing Service Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 149

According to our LPI (LP Information) latest study, the global Sanger Sequencing Service market size was valued at US$ 209 million in 2023. With growing demand in downstream market, the Sanger Sequencing Service is forecast to a readjusted size of US$ 206.7 million by 2030 with a CAGR of -0.2% during review period. The research report highlights the growth potential of the global Sanger Sequencing Service market. Sanger Sequencing Service are expected to show stable growth in the future ......

Global Whole Exome Sequencing Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Whole Exome Sequencing market size was valued at US$ 289.6 million in 2023. With growing demand in downstream market, the Whole Exome Sequencing is forecast to a readjusted size of US$ 633.2 million by 2030 with a CAGR of 11.8% during review period. The research report highlights the growth potential of the global Whole Exome Sequencing market. Whole Exome Sequencing are expected to show stable growth in the future market. Ho......

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 154

According to our LPI (LP Information) latest study, the global Single Nucleotide Polymorphism (SNP) Genotyping market size was valued at US$ 16530 million in 2023. With growing demand in downstream market, the Single Nucleotide Polymorphism (SNP) Genotyping is forecast to a readjusted size of US$ 66080 million by 2030 with a CAGR of 21.9% during review period. The research report highlights the growth potential of the global Single Nucleotide Polymorphism (SNP) Genotyping market. Single ......

Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125

According to our LPI (LP Information) latest study, the global CRISPR and CRISPR-Associated (Cas) Genes market size was valued at US$ 1354.3 million in 2023. With growing demand in downstream market, the CRISPR and CRISPR-Associated (Cas) Genes is forecast to a readjusted size of US$ 10020 million by 2030 with a CAGR of 33.1% during review period. The research report highlights the growth potential of the global CRISPR and CRISPR-Associated (Cas) Genes market. CRISPR and CRISPR-Associate......

Global Polymerase Chain Reaction (Pcr) Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 120

Market Overview of Global Polymerase Chain Reaction (Pcr) Products market: According to our latest research, the global Polymerase Chain Reaction (Pcr) Products market looks promising in the next 5 years. As of 2022, the global Polymerase Chain Reaction (Pcr) Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents......

Next Generation Sequencing - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 102

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Next Generation Sequencing, with both quanti......

Polymerase Chain Reaction (PCR) Products - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) Products, wi......

Global Genotyping Market Status and Outlook 2023-2028

Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 128

Genotyping is the technology that detects small genetic differences that can lead to major changes in phenotype, including both physical differences that make us unique and pathological changes underlying disease. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals wh......

Global Pyrosequencing Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101

Pyrosequencing is a method of DNA sequencing that detects light emitted from nucleotide bases.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital f......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs